Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-00-004028
Filing Date
2000-08-14
Accepted
2000-08-14 00:00:00
Documents
4
Period of Report
2000-06-30

Document Format Files

Seq Description Document Type Size
1 GELTEX PHARMACEUTICALS, INC. e10-q.txt 10-Q 42714
2 AMENDED AND RESTATED COLLABORATION AGREEMENT ex10-1.txt EX-10.1 174997
3 AMENDED AND RESTATED OPERATING AGREEMENT ex10-2.txt EX-10.2 44699
4 FINANCIAL DATA SCHEDULE ex27-1.txt EX-27.1 2135
  Complete submission text file 0000950135-00-004028.txt   266498
Mailing Address 152 SECOND AVE WALTHAM MA 02451
Business Address 153 SECOND AVE WALTHAM MA 02451 781-290-58
GELTEX PHARMACEUTICALS INC (Filer) CIK: 0001001425 (see all company filings)

EIN.: 043136767 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26872 | Film No.: 699525
SIC: 2834 Pharmaceutical Preparations